Search Results - "Elvidge, Jamie"

Challenges in synthesising cost-effectiveness estimates by Shields, Gemma E, Elvidge, Jamie

“…Economic evaluations help decision-makers faced with tough decisions on how to allocate resources. Systematic reviews of economic evaluations are useful as…”
Get full text

Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reporting by Vithlani, Jai, Hawksworth, Claire, Elvidge, Jamie, Ayiku, Lynda, Dawoud, Dalia

“…Objectives: Health economic evaluations (HEEs) help healthcare decision makers understand the value of new technologies. Artificial intelligence (AI) is…”
Get full text

Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations by Elvidge, Jamie, Hopkin, Gareth, Narayanan, Nithin, Nicholls, David, Dawoud, Dalia

“…Objectives: As the initial crisis of the COVID-19 pandemic recedes, healthcare decision makers are likely to want to make rational evidence-guided choices…”
Get full text

Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence by Pearson-Stuttard, Jonathan, Holloway, Sara, Polya, Rosie, Sloan, Rebecca, Zhang, Linxuan, Gregg, Edward W., Harrison, Katy, Elvidge, Jamie, Jonsson, Pall, Porter, Thomas

“…The prevalence of type 2 diabetes (T2DM) is increasing, but increasing longevity among persons with diagnosed diabetes may be is associated with more extensive…”
Get full text

A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM by Daly, Marie-Josée, Elvidge, Jamie, Chantler, Tracey, Dawoud, Dalia

“…In the UK, 4.7 million people are currently living with diabetes. This is projected to increase to 5 million by 2025. The direct and indirect costs of T1DM and…”
Get full text

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop by Claire, Ravinder, Elvidge, Jamie, Hanif, Shahid, Goovaerts, Hannah, Rijnbeek, Peter R, Jónsson, Páll, Facey, Karen, Dawoud, Dalia

“…Real-world evidence (RWE) in health technology assessment (HTA) holds significant potential for informing healthcare decision-making. A multistakeholder…”
Get full text

Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs by Gooding, Sarah, Lau, I-Jun, Sheikh, Mimi, Roberts, Pamela, Wong, Julia, Dickens, Emmy, Bullement, Ash, Elvidge, Jamie, Lee, Dawn, Ramasamy, Karthik

“…Double relapsed and/or refractory multiple myeloma (DRMM), MM that is relapsed and/or refractory to bortezomib and lenalidomide, carries a poor prognosis. The…”
Get full text

Outcome-based reimbursement in Central-Eastern Europe and Middle-East by Ádám, Ildikó, Callenbach, Marcelien, Németh, Bertalan, Vreman, Rick A., Tollin, Cecilia, Pontén, Johan, Dawoud, Dalia, Elvidge, Jamie, Crabb, Nick, van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh, Pisters-van Roy, Anke, Vincziczki, Áron, Almomani, Emad, Vajagic, Maja, Oner, Z. Gulsen, Matni, Mirna, Fürst, Jurij, Kahveci, Rabia, Goettsch, Wim G., Kaló, Zoltán

“…Outcome-based reimbursement models can effectively reduce the financial risk to health care payers in cases when there is important uncertainty or…”
Get full text

Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme by Cordingley, Lis, Nelson, Pauline A, Davies, Linda, Ashcroft, Darren, Bundy, Christine, Chew-Graham, Carolyn, Chisholm, Anna, Elvidge, Jamie, Hamilton, Matthew, Hilton, Rachel, Kane, Karen, Keyworth, Christopher, Littlewood, Alison, Lovell, Karina, Lunt, Mark, McAteer, Helen, Ntais, Dionysios, Parisi, Rosa, Pearce, Christina, Rutter, Martin, Symmons, Deborah, Young, Helen, Griffiths, Christopher EM

“…Background Psoriasis is a common, lifelong inflammatory skin disease, the severity of which can range from limited disease involving a small body surface area…”
Get full text

Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable Workshop by Elvidge, Jamie, Dawoud, Dalia

“…Background To date, health technology assessment (HTA) agencies have not been at the forefront of decision making regarding the adoption of interventions for…”
Get full text

Reporting standards to support cost-effectiveness evaluations of AI-driven health care by Elvidge, Jamie, Dawoud, Dalia

Get full text

Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations by Elvidge, Jamie, Summerfield, Ashley, Nicholls, David, Dawoud, Dalia

“…As healthcare systems continue to respond to the COVID-19 pandemic, cost-effectiveness evidence will be needed to identify which tests and treatments for…”
Get full text

Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe by Avşar, Tuba Saygın, Elvidge, Jamie, Hawksworth, Claire, Kenny, Juliet, Németh, Bertalan, Callenbach, Marcelien, Ringkvist, Johanna, Dawoud, Dalia

“…Health technology assessment (HTA) of advanced therapy medicinal products (ATMPs), such as high-cost and one-time cell and gene therapies, is particularly…”
Get full text

Living Health Technology Assessment: Issues, Challenges and Opportunities by Thokala, Praveen, Srivastava, Tushar, Smith, Robert, Ren, Shijie, Whittington, Melanie D., Elvidge, Jamie, Wong, Ruth, Uttley, Lesley

“…Health technology assessments (HTAs) are typically performed as one-off evaluations and can potentially become out-of-date due to the availability of new data,…”
Get full text

Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time by Shields, Gemma E., Pennington, Becky, Bullement, Ash, Wright, Stuart, Elvidge, Jamie

“…The impact of time on the applicability and relevance of historical economic evaluations can be considerable. Ignoring this may lead to the use of weak or…”
Get full text

Risk assessment scales to predict risk of hospital treated repeat self-harm: A cost-effectiveness modelling analysis by Quinlivan, Leah, Steeg, Sarah, Elvidge, Jamie, Nowland, Rebecca, Davies, Linda, Hawton, Keith, Gunnell, David, Kapur, Nav

“…•Evidence suggests risk scales for predicting repeat self-harm are in wide use but have poor accuracy.•We compared cost-effectiveness of formal risk scales to…”
Get full text

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK by Elvidge, Jamie, Bullement, Ash, Hatswell, Anthony J.

“…Introduction Until recently, treatment options for damage to cartilage in the knee were limited to the use of microfracture or, occasionally, mosaicplasty. The…”
Get full text

Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review by Shields, Gemma Elizabeth, Buck, Deborah, Elvidge, Jamie, Hayhurst, Karen Petra, Davies, Linda Mary

“…This review aims to assess the cost-effectiveness of psychological interventions for schizophrenia/bipolar disorder (BD), to determine the robustness of…”
Get more information

Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations by Elvidge, Jamie, Summerfield, Ashley, Knies, Saskia, Németh, Bertalan, Kaló, Zoltán, Goettsch, Wim, Dawoud, Dalia M

“…To develop best-practice guidance for health technology assessment (HTA) agencies when appraising diagnostic tests for SARS-CoV-2 and treatments for COVID-19…”
Get more information

Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology by Sarri, Grammati, Liu, Wei, Zabotka, Luke, Freitag, Andreas, Claire, Ravinder, Wangge, Grace, Elvidge, Jamie, Dawoud, Dalia, Bennett, Dimitri, Wen, Xuerong, Li, Xiaojuan, Rentsch, Christopher T., Uddin, Md Jamal, Ali, M. Sanni, Gokhale, Mugdha, Déruaz‐Luyet, Anouk, Moga, Daniela C., Guo, Jeff Jianfei, Zullo, Andrew R., Patorno, Elisabetta, Lin, Kueiyu Joshua

“…During the coronavirus disease 2019 (COVID‐19) pandemic, the urgency for updated evidence to inform public health and clinical care placed systematic…”
Get full text